Abstract
HbA1c is routinely used in the clinical laboratory to diagnose and monitor diabetes mellitus. Many methods have been standardized to provide precise and accurate results for normal patients. For the other common Hb variants, most of the methods are now relatively free of analytical interference.
In this webinar, Dr David Sacks and Dr. John Higgins, explains the clinical value of HbA1c in individual patient care; when an analytically correct result provides clinically misleading information due to red cell/hemoglobin lifespan. How should these patients be identified and managed so the best care can be provided to the patient? How can laboratory help?
Learning objectives
- Identify components contributing to glycation rate of Hb to form HbA1c
- Discuss which conditions can cause an artificial decrease/reduction in the levels of circulating HbA1c
- Review which conditions should prevent the use of HbA1c for monitoring/diagnosing diabetic patients
- Identify methods that indicate the presence of clinically significant hemoglobinopathies and/or thalassemia’s
Fill the form to watch the webinar
Speakers
CAPILLARYS 3 OCTA
Evolution makes the difference.
CAPILLARYS 3 TERA MC
The power of up to 36 capillaries in one automated high volume workcell.
MINICAP FLEX-PIERCING
The compact and affordable automation of Capillary Electrophoresis.
This section contains information intended for wide distribution and may therefore contain product details or information that is not available or valid in your country.
Please contact your local Sebia representative. Information intended for healthcare professionals.
Carefully read the instructions in the reagent package inserts and instrument manuals.